Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06843356 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Rescue Endovascular Treatment After Neurological Deterioration in Initially Mild Basilar Artery Occlusion in an Extended Time Window

Study acronym: RESCUE-BAO
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Sep 30, 2026 → Sep 30, 2027
See other at-risk trials from First Affiliated Hospital of Wannan Medical College

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 47 words
    • Secondary endpoints revised (6)
    • Collaborators expanded, about 178 words
    • Study title shortened, about 2 words
  2. Eligibility criteria expanded, about 14 words
    • Secondary endpoints revised (6)
    • Study description shortened, about 4 words
    v6
  3. Study sites: 1 to 2
    • Secondary endpoints revised (6)
    v5
  4. Primary completion pushed from Sep 30, 2026 to Sep 30, 2027
    • Start date: Jun 1, 2024 to Aug 1, 2025
    • Study completion pushed from Dec 31, 2026 to Dec 31, 2027
    • Secondary endpoints revised (6)
    v4
  5. Eligibility criteria expanded, about 5 wordsv3
  6. Study description shortened, about 13 words
    • Study title shortened, about 9 words
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A prospective, multicenter, open-label, blinded-endpoint, randomized controlled trial to evaluate whether best medical management (BMM) combined with endovascular therapy (EVT) improves neurological outcomes compared to BMM alone in patients with progressive acute mild ischemic stroke due to basilar artery occlusion within an extended time window.
Trial Details
NCT Number NCT06843356
Lead Sponsor First Affiliated Hospital of Wannan Medical College
Collaborators: The First Affiliated Hospital of the University of Science and Technology of China, First People's Hospital of Yulin, THE SECOND PEOPLE'S HOSPITAL, WUHU, People's Hospital of Guoyang County, Heyuan people's Hospital, The First Affiliated Hospital of Hainan Medical University, Wuwei City People's Hospital, People's Hospital of Lixin Country, Zhongshan Hospital Of Traditional Chinese Medicine, Xihua People's Hospital, Wuhan No.1 Hospital, The Fourth Hospital of Liuan, Huaibei Miner General Hospital, Huaibei, China., Guangdong Second Provincial General Hospital, The First Affiliated Hospital of University of South China, Maoming Hospital of Traditional Chinese Medicine, People's Hospital of Linquan County, Jiangsu Province Hospital of Traditional Chinese Medicine, Haiyan People's Hospital, Haiyan County People's Hospital, The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Yingshang County People's Hospital, The second affiliated hospital of Xuzhou medical university, The Central Hospital of Wuhan, Wuhan, Hubei, China, Suixi County Hospital of Traditional Chinese Medicine, Affiliated Jinling Hospital, Medical School of Nanjing University, Xiangtan Central Hospital, Xiangtan, Hunan, China, Feidong County Hospital of Traditional Chinese Medicine, Hefei, Anhui, China, Dongguan People's Hospital, Dongguan, Guangdong, China
Conditions
(from sponsor)		 Acute Mild Ischemic Stroke, Basilar Artery Occlusion, Rescue Endovascular Treatment, Extended Time Window
Enrollment 159 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov